CIK: 0001232621 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value ($000): $193,002 (66.5% shares, 33.5% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SALIX PHARMACEUTICALS INC | 300,000 | $46,872 | 24.3% | $66.15 | — | COM | 795435106 |
| HRTX | HERON THERAPEUTICS INC | 4,919,625 | $40,980 | 21.2% | $12.54 | -25.7% | COM | 427746102 |
| — | PDL BIOPHARMA INC | 25,974,000 | $37,456 | 19.4% | $1.41 | — | NOTE 2.875% 2/15/15 | 69329YAE4 |
| — | OPKO HEALTH INC | 14,000,000 | $18,760 | 9.7% | $1.04 | — | NOTE 3.0% 2/1/33 | 68375NAA1 |
| — | LA JOLLA PHARMACEUTICAL CO | 1,911,462 | $18,369 | 9.5% | $9.42 | — | COM | 503459604 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 182,300 | $13,155 | 6.8% | $62.32 | +5.5% | COM | 09061G101 |
| — | MERRIMACK PHARMACEUTICALS INC | 5,500,000 | $8,496 | 4.4% | $1.36 | — | NOTE 4.5% 7/15/20 | 590328AA8 |
| — | MIRATI THERAPEUTICS INC | 288,432 | $5,050 | 2.6% | $15.15 | — | COM | 60468T105 |
| — | HORIZON PHARMA PLC | 300,000 | $3,684 | 1.9% | $12.28 | — | SHS | G4617B105 |
| — | RXI PHARMACEUTICALS CORP | 50,219 | $100 | 0.1% | $1.99 | — | COM | 74979C303 |
| — | DENDREON CORP | 55,548 | $80 | 0.0% | $4.12 | — | COM | 24823Q107 |
| — | AMBIT BIOSCIENCES CORP | 46 | $0 | 0.0% | — | — | COM | 02318X100 |